State v. Pharmaceutical Companies
GPTKB entity
Statements (72)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:legal_case
|
| gptkbp:affects |
insurance policies
community health programs public perception of companies stock prices of companies |
| gptkbp:aims_to |
hold companies accountable
|
| gptkbp:can_include |
compensation for damages
|
| gptkbp:can_involve |
public health initiatives
multiple jurisdictions state attorneys general collaboration with NGOs whistleblower testimonies class action lawsuits collaborative agreements government investigations settlement funds for communities |
| gptkbp:can_lead_to |
policy advocacy
regulatory changes increased transparency greater accountability improved healthcare outcomes increased regulation of drugs improved patient access enhanced oversight enhanced consumer protections changes to drug formularies increased scrutiny of practices reforms in drug policies |
| gptkbp:can_result_in |
public awareness campaigns
changes in corporate governance fines increased funding for research changes to marketing practices |
| gptkbp:court |
pharmaceutical companies
|
| gptkbp:date |
varies by case
|
| gptkbp:has_a_focus_on |
legal advocacy groups
|
| https://www.w3.org/2000/01/rdf-schema#label |
State v. Pharmaceutical Companies
|
| gptkbp:impact |
healthcare costs
|
| gptkbp:influence |
legislative actions
international drug policies future litigation strategies |
| gptkbp:investigates |
regulatory bodies
|
| gptkbp:involves |
gptkb:pharmaceuticals
|
| gptkbp:is_a_basis_for |
consumer protection laws
|
| gptkbp:is_analyzed_in |
legal scholars
|
| gptkbp:is_applied_in |
gptkb:state_government
|
| gptkbp:is_cited_in |
legal precedents
|
| gptkbp:is_debated_in |
gptkb:deception
|
| gptkbp:is_influenced_by |
political climate
|
| gptkbp:is_often_associated_with |
healthcare inequities
economic impacts. |
| gptkbp:is_often_described_as |
complex litigation
|
| gptkbp:is_often_discussed_in |
gptkb:academic_research
legal forums |
| gptkbp:is_often_involved_in |
public debate
|
| gptkbp:is_often_settled_through |
mediation
|
| gptkbp:is_part_of |
healthcare reform discussions
larger legal trends |
| gptkbp:is_significant_for |
public health
consumer rights advocacy |
| gptkbp:is_sometimes_resolved_by |
trial verdicts
|
| gptkbp:issues |
drug pricing
|
| gptkbp:may_include_claims_of |
negligence
|
| gptkbp:may_involve_negotiations_with |
government agencies
|
| gptkbp:often_includes |
expert testimonies
|
| gptkbp:outcome |
gptkb:Roman_settlement
|
| gptkbp:related_to |
opioid crisis
|
| gptkbp:reported_by |
gptkb:media_outlets
|
| gptkbp:was_a_catalyst_for |
gptkb:social_movements
|
| gptkbp:was_a_response_to |
public outcry
|
| gptkbp:bfsParent |
gptkb:Minnesota's_attorney_general
|
| gptkbp:bfsLayer |
6
|